Misoprostol and Malignant neoplasm progression - a phase IV clinical study of FDA data

Summary:

Malignant neoplasm progression is reported as a side effect among people who take Misoprostol (misoprostol), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Lansoprazole, and have Adverse event.

The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Misoprostol. It is created by eHealthMe based on reports of 8,111 people who have side effects when taking Misoprostol from the FDA, and is updated regularly.

What is Misoprostol?

Misoprostol has active ingredients of misoprostol. It is often used in abortion. eHealthMe is studying from 8,222 Misoprostol users. Check the latest studies of Misoprostol.

What is Malignant neoplasm progression?

Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,508 drugs and 1,637 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

8,111 people reported to have side effects when taking Misoprostol.
Among them, 17 people (0.21%) have Malignant neoplasm progression.

Could Misoprostol cause Malignant neoplasm progression?

Among these 17 people:

How long have people been on Misoprostol when they have Malignant neoplasm progression? *

What is the gender of people who have Malignant neoplasm progression when taking Misoprostol? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Malignant neoplasm progression when taking Misoprostol? *

What are other drugs people take besides Misoprostol? *

What are other side effects people have besides Malignant neoplasm progression? *

Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 6 people, 35.29%
Bile Duct Cancer Stage Iii: 6 people, 35.29%
Metastases To Liver (cancer spreads to liver): 6 people, 35.29%
Prostate Cancer Metastatic: 4 people, 23.53%
Fatigue (feeling of tiredness): 4 people, 23.53%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 3 people, 17.65%
Bowel Movement Irregularity: 3 people, 17.65%
Body Temperature Increased: 3 people, 17.65%
Pain: 3 people, 17.65%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 35.29%
Adverse Event: 6 people, 35.29%
Prostate Cancer Metastatic: 3 people, 17.65%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 3 people, 17.65%
Metastases To Liver (cancer spreads to liver): 3 people, 17.65%
Cachexia (loss of weight): 3 people, 17.65%
Renal Cell Carcinoma (a kidney cancer): 1 person, 5.88%
Colon Cancer: 1 person, 5.88%
Carcinoid Tumor: 1 person, 5.88%
Breast Cancer Metastatic: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Misoprostol and have Malignant neoplasm progression?

- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Misoprostol:

Misoprostol (8,222 reports)

Browse all side effects of Misoprostol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,508 drugs)

Browse all the conditions that are associated with Malignant neoplasm progression:

Malignant neoplasm progression (1,637 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on misoprostol (the active ingredients of Misoprostol) and Misoprostol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.